Rothschild & CO Asset Management Us Inc. Iovance Biotherapeutics, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 418,929 shares of IOVA stock, worth $3.93 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

418,929

Previous 450,877 7.09%

Holding current value

$3.93 Million

Previous $4.32 Million 38.04%

% of portfolio

0.04%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $179,547 - $319,480	-31,948 Reduced 7.09%	418,929 $2.68 Million
Q3 2022 Nov 07, 2022	SELL	$9.53 - $13.11 $315,871 - $434,530	-33,145 Reduced 6.85%	450,877 $4.32 Million
Q2 2022 Aug 09, 2022	SELL	$6.38 - $18.33 $157,413 - $452,256	-24,673 Reduced 4.85%	484,022 $5.34 Million
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $1.5 Million - $2.31 Million	-120,918 Reduced 19.21%	508,695 $8.47 Million
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $1.58 Million - $2.64 Million	95,526 Added 17.89%	629,613 $12 Million
Q3 2021 Nov 09, 2021	SELL	$20.35 - $26.63 $1.21 Million - $1.59 Million	-59,667 Reduced 10.05%	534,087 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $1.23 Million - $2.49 Million	75,218 Added 14.51%	593,754 $15.4 Million
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $7.02 Million - $12.9 Million	-244,887 Reduced 32.08%	518,536 $16.4 Million
Q4 2020 Feb 08, 2021	SELL	$28.04 - $50.26 $4.09 Million - $7.33 Million	-145,864 Reduced 16.04%	763,423 $35.4 Million
Q3 2020 Nov 09, 2020	SELL	$27.75 - $36.3 $1.52 Million - $1.98 Million	-54,597 Reduced 5.66%	909,287 $29.9 Million
Q2 2020 Aug 10, 2020	BUY	$27.21 - $41.0 $1.28 Million - $1.93 Million	47,175 Added 5.15%	963,884 $26.5 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $12.5 Million - $24.9 Million	640,349 Added 231.71%	916,709 $27.4 Million
Q4 2019 Feb 12, 2020	BUY	$17.95 - $29.41 $4.96 Million - $8.13 Million	276,360 New	276,360 $7.65 Million

Others Institutions Holding IOVA

# of Institutions

323

Shares Held

239M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.48B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Iovance Biotherapeutics, Inc. Transaction History